Table 2A. Drug-related adverse events by maximum grade per patient (N = 28).

Adverse Event	Grade 1	Grade 2	Grade 3	Grade 4	Grade 3/4 (%)
Hematology
Lymphocytopenia	10 (36%)	3 (11%)	6 (21%)	0	21%
White Blood Count	8 (29%)	7 (25%)	7 (25%)	1 (4%)	29%
Neutropenia	1 (4%)	7 (25%)	8 (29%)	2 (7%)	36%
Thrombocytopenia	14 (50%)	3 (11%)	0	3 (11%)	11%
Anemia	9 (32%)	10 (36%)	3 (11%)	0	11%
Gastrointestinal disorders
Nausea	11 (39%)	1 (4%)	0	0	0%
Vomiting	3 (11%)	1 (4%)	0	0	0%
Gastroesophageal reflux disease	4 (14%)	0	0	0	0%
Constipation	2 (7%)	0	0	0	0%
Diarrhea	2 (7%)	0	0	0	0%
Chemistry
Hyponatremia	3 (11%)	0	1 (4%)	0	4%
Hypomagnesemia	1 (4%)	0	0	0	0%
Increased AST	4 (14%)	1 (4%)	1 (4%)	0	4%
Increased ALT	4 (14%)	0	0	0	0%
Other
Fatigue	8 (29%)	5 (18%)	0	0	0%
Carboplatin allergic reaction	0	0	0	0	0%
Skin rash	3 (11%)	1 (4%)	0	0	0%
Weight Loss	1 (4%)	0	0	0	0%
Headache	5 (18%)	0	0	0	0%